Southern Acids (malaysia) Bhd. · MYX:SAB

Southern Acids (malaysia) Bhd — Southern Acids (M) Berhad — Shareholder Meeting (August 2026)

15 slides from Southern Acids (malaysia) Bhd's shareholder meeting presentation, Aug 28, 2026

  1. Slide 1: Southern Acids (M) Berhad 45th Annual General Meeting

    SOUTHERN ACIDS (M) BERHAD 45th ANNUAL GENERAL MEETING 28 AUGUST 2026 SHAREHOLDERS’ BRIEFING

  2. Slide 2: Source of Information & Disclaimer

    SLIDE 1 SOURCE OF INFORMATION & DISCLAIMER Source of Information Used For The Presentation ❖ The Company’s 2026 Annual Report (“AR2026”); and ❖ All other information that is available from Bursa Malaysia Securities Berhad’s website. Disclaimer Information contained in this presentation is intended s

  3. Slide 3: Content

    SLIDE 2 CONTENT 1. Key Financial Highlights For The Financial Year Ended 31 March 2026 (“FY2026”) a. Southern Acids (M) Berhad b. The Respective Segments 2. Outlook For The Financial Year Ending 31 March 2027 (“FY2027”) a. The Respective Segments b. Southern Acids (M) Berhad 3. Questions & Answers

  4. Slide 4: Key Financial Highlights for FY2026

    SOUTHERN ACIDS (M) BERHAD KEY FINANCIAL HIGHLIGHTS FOR FY2026

  5. Slide 5: Key Financial Highlights - Southern Acids (M) Berhad (I)

    SLIDE 3 KEY FINANCIAL HIGHLIGHTS - SOUTHERNA ACIDS (M) BERHAD (I) FY2026 FY2025 Changes Changes RM’000 RM’000 RM’000 % Revenue 918,873 1,090,530 (171,657) (15.7%) Profit Before Tax (“PBT”) 75,520 72,263 3,257 4.5% /(Loss Before Tax)(“LBT”) Segment’s PBT/(LBT) Oleochemical Manufacturing (32,831) (23,

  6. Slide 6: Key Financial Highlights - Southern Acids (M) Berhad (II)

    SLIDE 4 KEY FINANCIAL HIGHLIGHTS - SOUTHERN ACIDS (M) BERHAD (II) FY2026 FY2025 Changes RM’000 RM’000 RM’000 % Profit After Tax And Minority Interest 37,378 36,702 676 1.8% Shareholders’ Equity 781,670 779,743 1,927 0.2% Net Assets Per Share (RM) 5.71 5.69 0.02 0.4% Earnings Per Share (Sen) 27.30 26

  7. Slide 7: Key Financial Highlights - Oleochemical Manufacturing

    SLIDE 5 KEY FINANCIAL HIGHLIGHTS - OLEOCHEMICAL MANUFACTURING FY2026 FY2025 Changes Changes RM’000 RM’000 RM’000 % Revenue 263,055 405,352 (142,297) (35.1%) PBT/(LBT) Core PBT/(LBT) (29,523) (26,500) (3,023) (11.4%) Non-Core PBT (3,308) 2,518 (5,826) (>100.0%) (32,831) (23,982) (8,849) (36.9%)

  8. Slide 8: Key Financial Highlights - Milling & Cultivation

    SLIDE 6 KEY FINANCIAL HIGHLIGHTS - MILLING & CULTIVATION FY2026 FY2025 Changes Changes RM’000 RM’000 RM’000 % Revenue 507,450 540,249 (32,799) (6.1%) PBT Core PBT 36,989 38,856 (1,867) (4.8%) Non-Core PBT 46,165 28,848 17,317 60.0% 83,154 67,704 15,450 22.8%

  9. Slide 9: Key Financial Highlights - Healthcare Services

    SLIDE 7 KEY FINANCIAL HIGHLIGHTS - HEALTHCARE SERVICES FY2026 FY2025 Changes Changes RM’000 RM’000 RM’000 % Revenue 125,489 122,539 2,950 2.4% PBT Core PBT 30,720 30,093 627 2.1% Non-Core PBT 3,749 3,750 (1) (0.0%) 34,469 33,843 626 1.8%

  10. Slide 10: Outlook for FY2027

    SOUTHERN ACIDS (M) BERHAD OUTLOOK FOR FY2027

  11. Slide 11: Outlook for FY2027 - Oleochemical Manufacturing

    SLIDE 8 OUTLOOK FOR FY2027 - OLEOCHEMICAL MANUFACTURING Challenging environment, key factors are as follows: I. Global uncertainties from the ongoing geopolitical tensions II. Intense competition from regional producers III. High feedstock costs IV. Volatility in USD/MYR exchange rate V. Rising prod

  12. Slide 12: Outlook for FY2027 - Milling & Cultivation

    SLIDE 9 OUTLOOK FOR FY2027 - MILLING & CULTIVATION Cautious outlook, key factors: i. Global uncertainties from the ongoing geopolitical tensions ii. Higher costs of fertiliser and fuel iii. Availability of external FFB and its purchasing price iv. Volatility of commodity prices v. Volatility in MYR/

  13. Slide 13: Outlook for FY2027 - Healthcare Services

    SLIDE 10 OUTLOOK FOR FY2027 - HEALTHCARE SERVICES Continues to demonstrate resilience, key factors: i. Strengthening its specialised healthcare offerings ii. Continues to enhancing patient experience and clinical capabilities iii. Investing in medical technology, talent development and healthcare in

  14. Slide 14: Outlook for FY2027 - Southern Acids (M) Berhad

    SLIDE 11 OUTLOOK FOR FY2027 - SOUTHERN ACIDS (M) BERHAD We remain cautiously optimistic, while external headwinds such as the ongoing geopolitical tensions, commodity price volatility, intense competition and regulatory developments may continue to pose challenges to our businesses.

  15. Slide 15: Thank You - Questions & Answers

    SOUTHERN ACIDS (M) BERHAD THANK YOU QUESTIONS & ANSWERS

Southern Acids (M) Berhad — Shareholder Meeting (August 2026) on 6ix